We discuss different methods of sample size calculation for two independent means, aiming to provide insight into the calculation of sample size at the design stage of a parallel two-arm randomised controlled trial (RCT). We compare different methods for sample size calculation, using published results from a previous RCT. We use variances and correlation coefficients to compare sample sizes using different methods, including 1. The choice of the primary outcome measure: post-intervention score vs. change from baseline score. 2. The choice of statistical methods: t-test without using correlation coefficients vs. analysis of covariance (ANCOVA).
Background
Sample size calculations for a parallel two-arm trial with a continuous outcome measure can be undertaken based on (i) a pre-specified difference between arms at the post-intervention endpoint and (ii) an estimate of the standard deviation (SD) of the outcome measure. If the outcome variable is also measured at baseline, an alternative outcome measure is change from baseline instead of the post-intervention measure. Use of this alternative outcome measure would result in a different power calculation from that obtained using the post-intervention as the outcome measure. It is possible to carry out a power calculation based on analysis of covariance (ANCOVA) where the baseline measure is included as a covariate in the analysis.
Sample size calculations typically use published results from trials similar to those under consideration. We use results from a published paper for the MOSAIC trial [1] to compare different methods for sample size calculation. We examine the assumptions made by each method for calculating sample size, and discuss the implications of these assumptions when calculating the required sample size for a new RCT. We aim to provide insight into sample size calculations at the design stage of an RCT.
We introduce the notion of change scores, and show how to derive variances of these change scores along with related correlation coefficients in Section 3, using published results. We then calculate and compare sample sizes using different methods in Section 4. A description of the simulation of different strengths of the correlation is presented in Section 5, with the aim of investigating its influence on the calculation of sample sizes using different methods. Section 6 discusses simplified sample size equations when certain assumptions are met. Finally, we consider implications in sample size calculation when planning an RCT in Section 7.
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Method

Published results of the MOSAIC trial
The MOSAIC trial is an RCT using continuous positive airway pressure (CPAP) for symptomatic obstructive sleep apnoea. The trial randomised 391 patients between two treatment arms (CPAP vs. standard care). It has two primary outcomes at 6 months: change in Epworth Sleepiness Score (ESS), and change in predicted 5-year mortality using a cardiovascular risk score. The authors also reported the energy/vitality score (referred to as the "energy score" hereafter) of the 36-item short-form questionnaire (SF-36). The change in SF-36 energy score at 6 months is a secondary outcome of the MOSAIC trial, and an investigator might conduct another RCT using it as the primary outcome. The online supplement of the MOSAIC paper [1] states that all data were analysed using multiple variable regression models adjusting for the minimisation variables and baseline value of the variable being analysed. Table 1 shows data concerning the SF-36 energy score, taken from Table 4 in the MOSAIC paper [1] . The outcome measure is energy score in the SF-36 questionnaire, measured at baseline and at 6 months postintervention. An increase in the energy score indicates an improvement in health status. The table shows that the adjusted treatment effect (6.6) is the same as the unadjusted treatment effect (10.8-4.2 = 6.6). The baseline mean scores are similar in both arms, being 49.7 and 49.8, respectively.
In the following sections, we show how to derive the variances of the change scores and correlation coefficients between baseline and 6 month measurements for both arms, using the results reported in Table 1 including "Mean change (SE)".
Deriving the sample variance of the change score
We use generic notation in this paper, noting that the proposed method is applicable to arbitrary continuous outcome measures. 
The SEs reported in for the sample size calculation in the following sections. We note that if ≠ r r c t , the sample size method via ANCOVA in this paper will not be valid; in this example, the values of r c and r t are very close, granting the validity of using ANCOVA for sample size calculation. We will discuss the implication of different values for r c and r t in later Sections.
Comparing different sample size calculations
The calculation of sample size will depend on whether the outcome measure is to be the post score or the change score, without and with baseline included as a covariate.
Sample size: t-test on post score Y 1
Using Y 1 as the outcome measure in our example, the pooled variance of Y 1 is (see Appendix) For a two-sided significance level α at power − β 1 , with pooled variance of s p 2 , the required number of patients per arm is approximately [2] . , respectively. In our example, the target mean difference is set to be the reported treatment effect in Table 1 In the trial design stage, the characteristics of the planned RCT will inevitably differ from those of a previously-published trial, and it is therefore desirable to calculate sample sizes over a range of variances. For example, assuming equal variance using = = σ s 22. 5
2 in Equation (2), the resulting sample sizes are = N 183 and = N 158, respectively. The pooled variance produces a modest sample size = N 170. In practice, one may choose to calculate N using the most conservative (i.e., the greatest) value of variances when designing a new RCT.
Sample size: t-test on change score
When using change score − Y Y ( 1 0 ) as the outcome measure, we can still use Equation (2) to calculate N , using the pooled variance of
.
1 0 in the previous section; substituting the latter into Equation (2) 
1 0 in the sample size calculation shown in Table 3 . We strongly recommend publishing resulting "mean change (SE)" in a study paper, because it allows the calculation of 
on the vertical axis. This visualisation will immediately reveal whether the assumption of a bivariate normal distribution is violated. It is possible that data will form two clusters corresponding to the control and intervention arms, respectively, which therefore violates the assumption. Borm, Fransen et al. [3] , used this relationship for sample size calculation via ANCOVA, but the authors did not explicitly discuss its assumption.
There are several other assumptions one must make before applying the variance deflation factor − r (1 ) 2 . In this paper, we give mathematical details in the Appendix and explicitly examine all the assumptions, summarised below:
1 , including all patients in both arms, follow a bivariate normal distribution. We recommend visualising the data to examine whether this assumption is violated, as discussed above. 2. The values of the correlation coefficient r between Y 0 and Y 1 are the same in both arms. This means that there exists no interaction between baseline score and the treatment arm. This assumption is adequately met in our example, where ≈ r 0.7 in both arms of the trial. 3. The variances of Y 1 , denoted σ 2 , are the same in both arms. We note that the variance of Y 0 , denoted τ 2 , does not affect the variance deflation factor, hence it does not have to take the same value in both arms. This assumption is mildly violated in our example, because 
while achieving the same power as a t-test on
2 , ANCOVA always produces a smaller sample size than a t-test, illustrated in the first row of Table 3 .
In our example, the variance of Y 1 in the control and intervention arms is different (22. 5 2 and 20. 9 2 , respectively), hence it does not meet the assumption of equal variance above (#3). In all sample size calculations in this paper (including those for which the results are shown in Table 3 ), we have used the target mean difference = δ 6.6, two-sided = α 0.05, allocation ratio = 1, achieving 80% power. All sample sizes are produced using the corresponding pooled variance derived in this paper. We used the PASS 15 system (NCSS, LLC) to validate our sample size calculation by equations, shown as "(N by PASS)" in Table 3 , and where "N by equation" refers to our derived N in previous sections. The algorithm implemented by the PASS software uses Borm, Fransen et al. [3] , in its reference for sample size via ANCOVA, and its results ("N by PASS") are similar to the "N by equation".
The efficiency (i.e. smaller N while maintaining the same statistical power) gained in ANCOVA by using r comes from making strong assumptions. We have used Equation (3) from Section 4.3 (i.e., sample size via ANCOVA) in Table 3 , but we note that its assumptions are not fully met in individual arms, and therefore one should not directly use the variance of individual arms for the sample size calculation in AN-COVA. In this instance, our approach is to use the pooled variance of both arms in the sample size equation via ANCOVA. Acknowledging its limitation in practice, one can produce sample sizes using a range of variances to gain a better sense of the required sample size.
In Table 3 , we have used = r 0.7 for sample size via ANCOVA, as stated previously. In both the "t-test" and "ANCOVA" methods, we have used the pooled variance = s p are used in all simulations in this section. The variance sum law shown in Equation (1) indicates that we have the following two options for simulation when varying the value of r: We show the simulated sample sizes of these two options above in the following sections. The simulated results using both options are shown in Table 4 below, and are plotted in Fig. 1 and Fig. 2 . The same parameter values as presented in Table 3 are used for simulation throughout this section. The results shown in Table 3 fixed in Equation (1). Fig. 2 shows the resulting sample sizes obtained by the three different methods, to be compared with Fig. 1. In Fig. 2 , the resulting N via ANCOVA remain the same as those shown in Fig. 1 by the values of r. ) will cross at = r 0.5. These two lines cross at = r 0.53 in Fig. 2 , indicating this assumption is only mildly violated.
Simplified sample size equations under assumptions
The variance sum law when assuming equal variance
Assuming Y 0 and Y 1 have the same variance σ 2 , the variance sum law (Equation (1)) can be simplified to , and hence give a reasonable estimate of sample size. This is further illustrated by Fig. 2 , where the long-dashed and short-dashed lines cross at = r 0.53, a close value to 0.5, indicating a mild violation of the assumption on equal variance.
In our example, Table 2 shows that Y 0 and Y 1 do not have equal variance, hence the above formula is not directly applicable. However, 
where equality occurs at = r 1. The left hand and right hand sides of Equation (5) When designing a new RCT, one needs to consider whether the duration of the planned trial will differ from that of previous trials. The correlation between Y 0 and Y 1 is likely to decrease (i.e., a smaller r) for an increased trial period, and vice versa.
In the example used in this paper, the derived correlation coefficient r is similar in both treatment arms, being approximately 0.7. If the correlation between Y 0 and Y 1 in the two treatment arms is different, one will need to consider the interaction between the treatment arm and baseline measure.
If "mean change (SE)" is not reported
If "mean change (SE)" is not reported for a study, we can calculate a range of potential variances of − Y Y ( 1 0 ) by setting a plausible range of values of r, using the variance sum law, as shown in Section 3.3. The simulation method shown in Section 5 can be used to compare sample sizes obtained using different methods at different values of r, providing a sense of the required sample size in the trial design stage.
Future work
In this paper we have used change score − Y Y ( 1 0 ) as a choice of Table 4 Simulated sample sizes at different values of r . "N by ANCOVA" produced by option 1 (plotted in Fig. 1 ) are the same as those produced by option 2 (plotted in Fig. 2 ). "N by t-test on post score" remains at a constant value of 170 throughout. In contrast, "N by t-test on change score" by option 1 and 2 are different, and are plotted in Figs. 1 Fig. 1 . Comparing values of sample size N produced using different methods at different values of r , using the same parameter values as are shown in Table 3 . outcome measure without questioning its validity. In fact, one should be cautious of using change score as the outcome measure, due to the well-known statistical phenomenon of "regression to the mean". This will be investigated in a future paper.
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X and Y . The bivariate normal density is given by the expression [4] 
